vimarsana.com

Page 3 - மார்பக புற்றுநோய் திரையிடல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pink Caravan furthers movement to safeguard women against breast cancer in UAE

Pink Caravan furthers movement to safeguard women against breast cancer in UAE 10 May 2021 The clinic has been conducting follow-up tests since January 2021, and 100 women out of 661 have been tested so far. Pink Caravan (PC), the breast cancer awareness initiative of the UAE-based non-profit, Friends of Cancer Patients (FOCP), has called upon women who previously underwent mammogram screenings at clinics during their annual UAE-wide breast cancer awareness campaign in 2019, to get themselves tested again at the Pink Caravan Medical Mobile Clinic, located at the Supreme Council for Family Affairs (SCFA) in Sharjah. The clinic has been conducting follow-up tests since January 2021, and 100 women out of 661 have been tested so far.

Friends of Cancer Patients call on female residents in UAE to undergo regular breast health check-ups

Sharjah: Residents who have availed of free mammogram screenings during the UAE-wide breast cancer awareness campaign in 2019 by Friends of Cancer Patients (FoCP), are advised to get themselves tested again at the Pink Caravan Medical Mobile Clinic, located at the Supreme Council for Family Affairs (SCFA) in Sharjah. FoCP said on Monday that the follow-up tests are mandated under the National Guidelines for Breast Cancer Screening and Diagnosis, which stipulate that women aged 40-69 years should undergo mammogram screening every two years. “Pink Caravan Medical Mobile Clinic conducts free breast cancer screenings across the seven emirates of the UAE, while raising awareness on the importance of early detection and diagnosis of breast cancer, its prevention and risk factors. The clinic has been conducting follow-up tests since January 2021,” FoCP noted.

Niramai s breast cancer screening test receives CE mark approval

Niramai’s breast cancer screening test receives CE mark approval Niramai’s breast cancer screening test receives CE mark approval 06 April 2021 | News NIRAMAI‘s Thermalytix solution can now be applied to all countries of Europe, as well as applicable to many Asian, African and Middle-East countries. Niramai, the deep-tech healthcare company at Bengaluru offering an innovative AI-based, radiation-free breast cancer screening test has now received the prestigious CE mark approval, ISO 13485 and MDSAP (Medical Device Single Audit Programme) International Certifications. The CE mark approval indicates that the product may be sold freely in any part of the European Economic Area. The ISO 13485 and MDSAP certifications endorse medical device manufacturers for their compliance with the international medical device quality standards and regulatory requirements.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.